NEW YORK, May 17 (GenomeWeb News) - Agilent Technologies yesterday reported an 8-percent drop in revenues and decreased earnings for its second fiscal quarter, though contributions from the life sciences and chemical analys segment grew 3 percent.
Revenue for the quarter ended April 30 fell to $1.7 billion from $1.8 billion during the same period last year. Receipts from the company's life sciences and chemical analysis segment increased to $344 million from $333 during the same quarter.
Research and development costs increased slightly, to $248 million from $237 million during the second quarter of 2004.
Net earnings for the quarter fell to $95 million, or $.19 per share, from $104 million, or $.21 per share, during the year-ago period.
As of April 30, Agilent had $2.7 billion in cash and cash equivalents.